RDTCF (Rapid Dose Therapeutics) OCF Margin %: -40.69% (As of Nov. 2025)


RDTCF Rapid Dose Therapeutics Corp RDTCF
27 GF Score
Price $0.08
GF Value $0.30
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rapid Dose Therapeutics OCF Margin %?

Rapid Dose Therapeutics RDTCF -11.11% 27 OCF Margin % is -40.69% as of Nov. 2025. GuruFocus rates RDTCF with a GF Score™ of 27/100 and a GF Value™ of $0.30 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 947 Biotechnology companies, Rapid Dose Therapeutics ranks better than 54.91% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Rapid Dose Therapeutics's Cash Flow from Operations for the three months ended in Nov. 2025 was $-0.19 Mil. Rapid Dose Therapeutics's Revenue for the three months ended in Nov. 2025 was $0.47 Mil. Therefore, Rapid Dose Therapeutics's OCF Margin % for the quarter that ended in Nov. 2025 was -40.69%.

As of today, Rapid Dose Therapeutics's current OCF Yield % is -7.42%.

The historical rank and industry rank for Rapid Dose Therapeutics's OCF Margin % or its related term are showing as below:

RDTCF' s OCF Margin % Range Over the Past 10 Years
Min: -3002.97   Med: -193.17   Max: -55.01
Current: -34.76

During the past 13 years, the highest OCF Margin % of Rapid Dose Therapeutics was -55.01%. The lowest was -3002.97%. And the median was -193.17%.

RDTCF's OCF Margin % is ranked better than
54.91% of 947 companies
in the Biotechnology industry
Industry Median: -64.23 vs RDTCF: -34.76

Rapid Dose Therapeutics OCF Margin % Related Terms

Rapid Dose Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Rapid Dose Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics OCF Margin % Chart

Rapid Dose Therapeutics Annual Data
Trend Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -214.96 -171.26 -120.22 -224.87 -55.01

Rapid Dose Therapeutics Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -52.92 0.64 -55.58 -38.93 -40.69

RDTCF vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Rapid Dose Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's OCF Margin % falls into.


RDTCF
27GF Score
Rapid Dose Therapeutics Corp RDTCF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rapid Dose Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Rapid Dose Therapeutics's OCF Margin for the fiscal year that ended in Feb. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Feb. 2025 )/Revenue (A: Feb. 2025 )
=-0.802/1.458
=-55.01 %

Rapid Dose Therapeutics's OCF Margin for the quarter that ended in Nov. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Nov. 2025 )/Revenue (Q: Nov. 2025 )
=-0.19/0.467
=-40.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -40.69% mean?
Rapid Dose Therapeutics (RDTCF) has a OCF Margin % of -40.69% as of Nov. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rapid Dose Therapeutics and its competitors. According to the industry distribution chart, Rapid Dose Therapeutics ranks #427 out of 947 companies in the Biotechnology industry, placing it in the top 45.1%.
Is Rapid Dose Therapeutics' OCF Margin % too high?
Rapid Dose Therapeutics' current OCF Margin % is -40.69%. Based on the distribution chart, Rapid Dose Therapeutics ranks #427 out of 947 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Rapid Dose Therapeutics has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rapid Dose Therapeutics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Rapid Dose Therapeutics ranks #427 out of 947 companies for OCF Margin %. This puts Rapid Dose Therapeutics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rapid Dose Therapeutics and its competitors. Rapid Dose Therapeutics's current OCF Margin % is -40.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Dose Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Rapid Dose Therapeutics (RDTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.30, compared to a current price of $0.08 — trading 73.3% below its estimated fair value. The current OCF Margin % is -40.69%. Rapid Dose Therapeutics' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Rapid Dose Therapeutics (RDTCF), the current OCF Margin % is -40.69% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rapid Dose Therapeutics (RDTCF) Overvalued in 2026?

Based on GuruFocus' analysis, Rapid Dose Therapeutics stock appears to be undervalued. The current stock price of $0.08 is trading 73.3% below its estimated GF Value™ of $0.30. GuruFocus considers Rapid Dose Therapeutics to be Possible Value Trap.

Key valuation signals for RDTCF:

  • OCF Margin %: -40.69%
  • GF Value™: $0.30 vs. price of $0.08 (73.3% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the RDTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rapid Dose Therapeutics Business Description

Other Exchanges DOSE:Canada
Address 1121 Walkers Line, Unit 3a, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
27GF Score

Get the complete analysis for RDTCF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.30
GF Value